AbbVie's Marketing Of AndroGel 'Insidious,' Jury Told
Attorneys for a man who had a heart attack while using AbbVie Inc.'s testosterone replacement therapy drug AndroGel told an Illinois federal jury Tuesday the company's efforts to expand the drug's...To view the full article, register now.
Already a subscriber? Click here to view full article